Most bought healthcare stocks in Q3 2023
See which Healthcare stocks institutional investors increased the most in Q3 2023, measured as net growth in reported share positions from Q2 2023 into Q3 2023. Notable additions at the top of this list include NOVO-NORDISK A/S-SPONS ADR (NVO), BAXTER INTERNATIONAL INC (BAX), CVS HEALTH CORP (CVS), AVANTOR INC (AVTR). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Explore more:
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| NVO | NOVO-NORDISK A/S-SPONS ADR | 15,473,345 | $734.83M | 2 | 7 | 0 | 0 | 9 |
| BAX | BAXTER INTERNATIONAL INC | 15,244,942 | $576.43M | 3 | 4 | 4 | 0 | 14 |
| CVS | CVS HEALTH CORP | 10,943,203 | $874.67M | 1 | 11 | 5 | 3 | 18 |
| AVTR | AVANTOR INC | 9,536,237 | $259.07M | 1 | 2 | 4 | 0 | 10 |
| TEVA | TEVA PHARMACEUTICAL-SP ADR | 5,005,708 | $100.97M | 1 | 2 | 3 | 1 | 7 |
| PRVA | PRIVIA HEALTH GROUP INC | 4,413,144 | $90.31M | 0 | 2 | 0 | 1 | 2 |
| CI | THE CIGNA GROUP | 3,575,864 | $1.12B | 1 | 4 | 1 | 3 | 8 |
| PACB | PACIFIC BIOSCIENCES OF CALIF | 3,514,442 | -$105.22M | 1 | 1 | 0 | 0 | 3 |
| OSCR | OSCAR HEALTH INC - CLASS A | 2,957,590 | -$2.57M | 0 | 4 | 0 | 0 | 4 |
| OPCH | OPTION CARE HEALTH INC | 2,456,914 | $63.05M | 1 | 2 | 0 | 0 | 3 |
| RXRX | RECURSION PHARMACEUTICALS-A | 1,788,081 | $17.21M | 0 | 1 | 0 | 1 | 1 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 1,626,823 | $88.78M | 0 | 3 | 1 | 1 | 4 |
| CLOV | CLOVER HEALTH INVESTMENTS CO | 1,559,520 | $3.89K | 0 | 1 | 0 | 0 | 3 |
| QSI | QUANTUM-SI INC | 1,470,430 | $1.15M | 0 | 1 | 0 | 1 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | 1,398,222 | -$60.12M | 0 | 6 | 8 | 0 | 19 |
| BHC | BAUSCH HEALTH COS INC | 1,307,714 | $10.92M | 1 | 2 | 0 | 0 | 5 |
| EVH | EVOLENT HEALTH INC - A | 1,085,558 | $24.20M | 0 | 1 | 0 | 0 | 1 |
| LLY | ELI LILLY & CO | 999,423 | $595.01M | 1 | 9 | 5 | 0 | 16 |
| ISRG | INTUITIVE SURGICAL INC | 977,085 | $189.59M | 3 | 4 | 5 | 1 | 12 |
| VKTX | VIKING THERAPEUTICS INC | 971,810 | -$6.83M | 0 | 1 | 0 | 1 | 1 |
| CRL | CHARLES RIVER LABORATORIES | 902,437 | -$11.60M | 1 | 5 | 1 | 0 | 7 |
| A | AGILENT TECHNOLOGIES INC | 867,037 | -$128.21M | 2 | 2 | 5 | 0 | 10 |
| TGTX | TG THERAPEUTICS INC | 852,416 | $99.80K | 1 | 1 | 0 | 0 | 2 |
| VEEV | VEEVA SYSTEMS INC-CLASS A | 779,753 | $175.74M | 1 | 2 | 6 | 1 | 10 |
| ADPT | ADAPTIVE BIOTECHNOLOGIES | 768,256 | -$45.21M | 0 | 1 | 1 | 0 | 3 |
| IRWD | IRONWOOD PHARMACEUTICALS INC | 700,545 | $1.52M | 0 | 2 | 0 | 1 | 2 |
| THC | TENET HEALTHCARE CORP | 689,168 | $23.33M | 0 | 2 | 2 | 0 | 4 |
| EW | EDWARDS LIFESCIENCES CORP | 650,360 | -$11.85M | 2 | 4 | 2 | 1 | 10 |
| EXEL | EXELIXIS INC | 608,233 | $952.86K | 2 | 2 | 0 | 0 | 4 |
| LFST | LIFESTANCE HEALTH GROUP INC | 601,270 | $1.31M | 0 | 2 | 0 | 0 | 2 |
| DXCM | DEXCOM INC | 588,348 | $57.17M | 0 | 4 | 2 | 1 | 6 |
| ALLK | ALLAKOS INC | 579,548 | -$212 | 0 | 1 | 0 | 0 | 1 |
| RGEN | REPLIGEN CORP | 550,396 | $87.54M | 1 | 1 | 0 | 0 | 2 |
| AZN | ASTRAZENECA PLC-SPONS ADR | 550,318 | $1.41M | 0 | 3 | 3 | 1 | 7 |
| VSTM | VERASTEM INC | 543,700 | $5.94M | 0 | 1 | 1 | 0 | 2 |
| HOLX | HOLOGIC INC | 510,497 | -$74.15M | 0 | 4 | 4 | 0 | 8 |
| ZTS | ZOETIS INC | 504,220 | $8.23M | 1 | 7 | 4 | 0 | 14 |
| WAT | WATERS CORP | 494,502 | $59.52M | 1 | 4 | 2 | 1 | 7 |
| OPK | OPKO HEALTH INC | 487,290 | $597 | 0 | 1 | 0 | 0 | 1 |
| ILMN | ILLUMINA INC | 473,914 | -$197.49M | 1 | 3 | 3 | 1 | 8 |
| VRTX | VERTEX PHARMACEUTICALS INC | 470,603 | $26.36M | 1 | 5 | 3 | 0 | 9 |
| ACET | ADICET BIO INC | 466,597 | $416 | 0 | 1 | 0 | 0 | 1 |
| OGI | ORGANIGRAM HOLDINGS INC | 460,948 | $608 | 1 | 0 | 0 | 0 | 1 |
| TVTX | TRAVERE THERAPEUTICS INC | 439,109 | -$6.06K | 0 | 1 | 0 | 0 | 1 |
| EMBC | EMBECTA CORP | 426,997 | -$9.79M | 1 | 1 | 1 | 1 | 3 |
| NTLA | INTELLIA THERAPEUTICS INC | 422,568 | -$73.90M | 0 | 1 | 1 | 0 | 2 |
| IMUX | IMMUNIC INC | 422,500 | $460 | 0 | 1 | 0 | 0 | 1 |
| PFMT | PERFORMANT FINANCIAL CORP | 411,224 | $396.48K | 0 | 1 | 1 | 0 | 2 |
| BEAM | BEAM THERAPEUTICS INC | 397,800 | -$56.53M | 0 | 1 | 1 | 0 | 2 |
| KOD | KODIAK SCIENCES INC | 383,431 | -$1.40K | 0 | 1 | 0 | 0 | 1 |
Frequently asked questions about Most bought healthcare stocks in Q3 2023
What are the most bought Healthcare stocks in Q3 2023?
The most bought healthcare stocks in Q3 2023 are those with the largest increase in reported share counts across institutional investors compared to Q2 2023, based on SEC 13F filings.
Which healthcare stocks did institutional investors added to the most in Q3 2023?
Among filers in this sector, net additions were largest in companies such as NOVO-NORDISK A/S-SPONS ADR (NVO), BAXTER INTERNATIONAL INC (BAX), CVS HEALTH CORP (CVS), based on aggregated 13F data.
How is institutional buying calculated?
Buying is calculated by summing the net increase in shares reported by institutional investors between two consecutive quarterly 13F snapshots (compared to Q2 2023).
Does this include all institutional owners?
Yes. These rankings aggregate SEC 13F filings from all institutional investors in our database, not only the investors we track individually.
Are these trades real-time?
No. 13F filings are reported quarterly and may be delayed by up to 45 days. The data reflects positions at the end of the reporting period, not real-time trading activity.